GAAD Archives - Clinical Value of Diagnostics

LEAD 2025

12 February 2026

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

LEAD 2025

12 February 2026

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Health Economics

5 March 2024

Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis

A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early stage hepatocellular carcinoma in an international cohort

Digital Algorithms

9 December 2022

A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort

This study compared the clinical performance of the Elecsys GALAD (gender [sex], age, alpha-fetoprotein [AFP] Lens culinaris agglutinin-reactive fraction of AFP [AFP-L3] and protein-induced by vitamin…

GAAD

LEAD Perspective: Evaluating GAAD – A Malaysian Multicentre Study

LEAD Perspective: Asia Pacific Consensus Statement on the clinical and economic utility of biomarker-based algorithms in the early detection and surveillance of HCC

Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost–effectiveness analysis

A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort

Be the first to receive updates, event opportunities, and thought leadership insights.